People might attribute midnight bouts of chest pain or waves of nausea to food poisoning, stress or a stubborn case of indigestion, but Rutgers Health researchers suggest that knowing your family's ...
The National Institute for Health and Care Excellence (NICE) has recommended durvalumab (IMFINZI, AstraZeneca) with gemcitabine and cisplatin as an option for treating locally advanced, unresectable, ...
PSC Affects Outcomes in Paediatric IBD Patients with paediatric-onset IBD and concomitant primary sclerosing cholangitis have substantially worse outcomes, with elevated risks for cancer and death.
Please provide your email address to receive an email when new articles are posted on . Researchers reported a 41% confirmed ORR among patients with HER2-positive disease. No patients with ...
Credit: Jazz Pharmaceuticals Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor. Findings showed the ORR was 52% (95% CI, 39-65), of which ...
Keytruda, combined with gemcitabine and cisplatin, is approved for advanced biliary tract cancer, showing a 17% reduction in death risk compared to chemotherapy alone. The KEYNOTE-966 trial indicated ...
Hosted on MSN
What To Know About Primary Biliary Cholangitis (PBC)
PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage symptoms like itching. There is no cure for ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- ...
Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old now impacted by the disease. However, despite this, knowledge about these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results